Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience
Abdulsamet ErdenFurkan CeylanEmine DuranBayram FarisoğullarıErtuğrul Çağri BölekGözde Kübra YardimciLevent KilicAli AkdoganÖmer KaradağŞaziye Şule Apraş BilgenSedat KirazAli Ihsan ErtenliUmut KalyoncuPublished in: Turkish journal of medical sciences (2021)
Tofacitinib is effective as monotherapy or in combination with csDMARDs. It is a well-tolerated treatment option in Turkish RA patients.